foto 01

Excellence
in Corporate Development

    • January 2018
    Meet us at the JP Morgan Conference, San Francisco
    • November 2017
    Binder Associates GmbH advised Glycotope on the sale of Gycotope Biotechnology Manufacturing Site
    • August 2017
    Binder Associates GmbH advised Natrix Separations Inc. on the exit preparation and sale to Merck
    • January 2017
    Binder Associates advised world–wide acting family office on the sale of a biopharmaceutical portfolio company
    • January 2017
    Meet us at the JP Morgan Conference, 2017 San Francisco
    • September 2016
    Binder Associates GmbH advised Biomeva Holding GmbH on the sale of Biomeva GmbH to Asahi Glass (AGC)
    • July 2016
    Binder Associates successfuly initiates funded collaboration between a client and a large Pharma company
    • September 2015
    10th Binder Associates Business Development Forum
    • July 2015
    Binder Associates GmbH supported Cellca GmbH in the sale to Sartorius AG
    • February 2015
    Binder Associates GmbH advised Bionet Holding on the sale of scil animal care company to Henry Schein Inc.
    • February 2014
    Start of an exit preparation project with a Germany based technology provider
    • November 2013
    Binder Associates and Freshfields advised Bionet on the acquisition of Scil Proteins by Wacker Biotech
    • 2012
    Succesful outlicensing of a biologics project

      For more information please contact info@binder-associates.de

        Binder Associates

        Rankinestraße 4 · 86899 Landsberg am Lech

        Phone: +49 8191 9856 335 · Mail: info@binder-associates.de